-+ 0.00%
-+ 0.00%
-+ 0.00%

Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate

Benzinga·11/06/2025 13:34:31
Listen to the news
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.71) per share which missed the analyst consensus estimate of $(6.50) by 3.15 percent. This is a 59.21 percent increase over losses of $(16.45) per share from the same period last year.